ORBIMED ADVISORS LLC – Gracell Biotechnologies Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$25.38M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
-41.45%
quarter
Gracell Biotechnologies Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -17.97M | $3.22 | 7.88M | |
| Q2 2022 | share | 0.00% | 0 shares | 24.99M | $5.5 | 7.88M | |
| Q1 2022 | share | 0.00% | 0 shares | -29.25M | $2.33 | 7.88M | |
| Q4 2021 | share | 0.00% | 0 shares | -61.73M | $6.36 | 7.88M | |
| Q3 2021 | share | 0.00% | 0 shares | 6.86M | $13.87 | 7.88M | |
| Q2 2021 | share | 0.00% | 0 shares | -18.92M | $13 | 7.88M | |
| Q1 2021 | share | Increase | 0.00% | 7.88M shares | 121.42M | $15.4 | 7.88M |